Oxford trial chief says its Covid vaccine could still be ready at a similar time to others
Staff at CSL are seen working in the lab on Nov. 8 in Melbourne, Australia. CSL will begin manufacturing AstraZeneca-Oxford University Covid-19 vaccine from Monday.
Darrian Traynor | Getty Images News | Getty Images
LONDON — The coronavirus vaccine being developed by the University of Oxford and AstraZeneca could still be made available at a similar time to the other leading candidates, according to the head of Oxford’s vaccine trial.
The comments come shortly after a peer-reviewed analysis of phase two trials, published Thursday, showed the Oxford-AstraZeneca shot triggered a robust immune response in older adults.
The findings have raised hopes that it may be able to protect age groups most at risk from Covid-19.
Professor Andrew Pollard, director of the Oxford Vaccine Group, said that the researchers were “really delighted” with the findings, adding he was “optimistic” phase three data …continued .
[Source: CNBC News]